These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3550377)

  • 21. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans.
    Saccà L; Sherwin R; Hendler R; Felig P
    J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stimulation of glucose production through hormone secretion and other mechanisms during insulin-induced hypoglycemia.
    Frizzell RT; Hendrick GK; Brown LL; Lacy DB; Donahue EP; Carr RK; Williams PE; Parlow AF; Stevenson RW; Cherrington AD
    Diabetes; 1988 Nov; 37(11):1531-41. PubMed ID: 3053302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Restoration of stable metabolic conditions during islet suppression in dogs.
    Bradley DC; Bergman RN
    Am J Physiol; 1992 Apr; 262(4 Pt 1):E532-8. PubMed ID: 1348903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Altered metabolic and hormonal responses to epinephrine and beta-endorphin in human obesity.
    Giugliano D; Cozzolino D; Salvatore T; Torella R; Franchimont P; D'Onofrio F; Lefebvre PJ
    J Clin Endocrinol Metab; 1988 Aug; 67(2):238-44. PubMed ID: 2969000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of ketogenesis by epinephrine and norepinephrine in the overnight-fasted, conscious dog.
    Steiner KE; Fuchs H; Williams PE; Stevenson RW; Cherrington AD; Alberti KG
    Diabetes; 1985 May; 34(5):425-32. PubMed ID: 3886459
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Somatostatin-induced changes in insulin and glucagon secretion in normal and diabetic dogs.
    Sakurai H; Dobbs R; Unger RH
    J Clin Invest; 1974 Dec; 54(6):1395-402. PubMed ID: 4436439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extrapancreatic glucagon in control of glucose turnover in depancreatized dogs.
    Ross G; Lickley L; Vranic M
    Am J Physiol; 1978 Feb; 234(2):E213-19. PubMed ID: 623297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of an acute increase in epinephrine and cortisol on carbohydrate metabolism during insulin deficiency.
    Goldstein RE; Abumrad NN; Lacy DB; Wasserman DH; Cherrington AD
    Diabetes; 1995 Jun; 44(6):672-81. PubMed ID: 7789632
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of somatostatin on glucose homeostasis in conscious long-fasted dogs.
    Stevenson RW; Steiner KE; Hendrick GK; Cherrington AD
    Am J Physiol; 1987 Oct; 253(4 Pt 1):E435-42. PubMed ID: 2889363
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin sensitively controls the glucagon response to mild hypoglycemia in the dog.
    Igawa K; Mugavero M; Shiota M; Neal DW; Cherrington AD
    Diabetes; 2002 Oct; 51(10):3033-42. PubMed ID: 12351444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of C-terminal fragments of glucagon on insulin secretion in dogs.
    Ohneda A; Ohneda K
    Metabolism; 1994 Jun; 43(6):771-5. PubMed ID: 8201969
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence against important catecholamine compensation for absent glucagon counterregulation.
    De Feo P; Perriello G; Torlone E; Fanelli C; Ventura MM; Santeusanio F; Brunetti P; Gerich JE; Bolli GB
    Am J Physiol; 1991 Feb; 260(2 Pt 1):E203-12. PubMed ID: 1996624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Failure of somatostatin to modify effect of glucagon on carbohydrate metabolism in the dog.
    Cherrington AD; Lacy WW; Williams PE; Steiner KE
    Am J Physiol; 1983 Jun; 244(6):E596-602. PubMed ID: 6134474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blood glucose control in healthy subject and patients receiving intravenous glucose infusion or total parenteral nutrition using glucagon-like peptide 1.
    Nauck MA; Walberg J; Vethacke A; El-Ouaghlidi A; Senkal M; Holst JJ; Gallwitz B; Schmidt WE; Schmiegel W
    Regul Pept; 2004 Apr; 118(1-2):89-97. PubMed ID: 14759561
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevated growth hormone levels and insulin resistance in patients with cirrhosis of the liver.
    Shankar TP; Fredi JL; Himmelstein S; Solomon SS; Duckworth WC
    Am J Med Sci; 1986 Apr; 291(4):248-54. PubMed ID: 3518447
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of glucagon in the pathogenesis of the endogenous hyperglycemia of diabetes mellitus.
    Sakurai H; Dobbs RE; Unger RH
    Metabolism; 1975 Nov; 24(11):1287-97. PubMed ID: 1186499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of glucagon-like peptide-1(7-36)-amide on initial splanchnic glucose uptake and insulin action in humans with type 1 diabetes.
    Vella A; Shah P; Basu R; Basu A; Camilleri M; Schwenk FW; Holst JJ; Rizza RA
    Diabetes; 2001 Mar; 50(3):565-72. PubMed ID: 11246876
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Importance of basal glucagon in maintaining hepatic glucose production during a prolonged fast in conscious dogs.
    Hendrick GK; Wasserman DH; Frizzell RT; Williams PE; Lacy DB; Jaspan JB; Cherrington AD
    Am J Physiol; 1992 Sep; 263(3 Pt 1):E541-9. PubMed ID: 1415534
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intraportal GLP-1 infusion increases nonhepatic glucose utilization without changing pancreatic hormone levels.
    Johnson KM; Edgerton DS; Rodewald T; Scott M; Farmer B; Neal D; Cherrington AD
    Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E1085-91. PubMed ID: 17684104
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of plasma amino acid and hormone levels on renal hemodynamics in humans.
    Castellino P; Giordano C; Perna A; DeFronzo RA
    Am J Physiol; 1988 Sep; 255(3 Pt 2):F444-9. PubMed ID: 2901229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.